ANTI LKM (LIVER KIDNEY MICROSOMAL) ANTIBODIES - IFA

The Anti-LKM (Liver Kidney Microsomal) Antibodies IFA Test is a specialized blood test that detects Anti-Liver Kidney Microsomal (Anti-LKM) antibodies using the Indirect Immunofluorescence Assay (IFA) method. These autoantibodies are primarily associated with Type 2 Autoimmune Hepatitis (AIH Type 2), a rare autoimmune liver disease in which the immune system mistakenly attacks healthy liver cells, leading to chronic inflammation and liver damage.

The Anti-LKM IFA Test plays an important role in evaluating autoimmune liver disorders and helps differentiate Autoimmune Hepatitis from other liver diseases such as viral hepatitis, fatty liver disease, and drug-induced liver injury. The test is often performed together with other autoimmune liver antibody tests and liver function assessments for a comprehensive evaluation.

Benefits of the Test

• Detects Anti-LKM antibodies using the IFA method.
• Helps diagnose Type 2 Autoimmune Hepatitis.
• Supports evaluation of autoimmune liver diseases.
• Assists in differentiating autoimmune hepatitis from other liver disorders.
• Helps guide treatment planning and disease monitoring.
• Complements other autoimmune liver antibody tests.

Why Doctors Recommend This Test

Doctors may recommend the Anti-LKM IFA Test for individuals with symptoms or laboratory findings suggestive of autoimmune liver disease, including:

• Persistent fatigue
• Yellowing of the skin or eyes (jaundice)
• Abdominal discomfort
• Elevated liver enzymes (ALT and AST)
• Dark-colored urine
• Loss of appetite
• Nausea
• Unexplained chronic liver inflammation

The test is commonly ordered with Anti-Smooth Muscle Antibody (ASMA), Anti-Mitochondrial Antibody (AMA), Antinuclear Antibody (ANA), Liver Function Tests (LFTs), Serum Immunoglobulin G (IgG), viral hepatitis markers, and liver imaging studies.

Preparation Before Test

• No fasting is generally required.
• Continue regular medications unless advised otherwise by your physician.
• Inform your healthcare provider about liver disease, autoimmune disorders, and current medications.
• A blood sample is collected for laboratory analysis.

Normal Reporting Time

Reporting Time: Usually 3–7 working days, depending on laboratory processing protocols.

Who Should Take This Test?

This test is recommended for:

• Individuals with suspected autoimmune hepatitis.
• Patients with persistently elevated liver enzymes.
• Individuals with unexplained chronic liver disease.
• Patients undergoing evaluation for autoimmune liver disorders.
• Individuals referred by hepatologists or gastroenterologists.
• Children and young adults with suspected Type 2 Autoimmune Hepatitis, when clinically indicated.

Patient-Friendly Summary

The Anti-LKM (Liver Kidney Microsomal) Antibodies IFA Test is a blood test that detects antibodies directed against proteins found in liver and kidney cells. These antibodies are most commonly associated with Type 2 Autoimmune Hepatitis, a condition in which the immune system attacks the liver, causing chronic inflammation. Symptoms may include fatigue, jaundice, abdominal discomfort, loss of appetite, and abnormal liver function tests. This test helps doctors identify autoimmune liver disease, distinguish it from other causes of liver damage, and plan appropriate treatment. It is a safe blood test that generally does not require fasting.